Protagonist Therapeutics Inc (PTGX)

Exchange
NASDAQ
Symbol
PTGX
Sector
Life Sciences
Industry
Pharmaceutical Preparations
Description
Protagonist Therapeutics, Inc., a clinical-stage biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address unmet medical needs. The company is headquartered in Newark, California.
Country
USA

Stock price

At close: September 24, 2025

  • Open
    65.00
  • High
    66.70
  • Low
    63.83
  • Close
    65.95
  • Volume
    857,043

Financial ratios

Dec 31, 2024